{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:13:16Z","timestamp":1792131196900,"version":"4.4.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T00:00:00Z","timestamp":1383177600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003723","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T03:12:01Z","timestamp":1383275521000},"page":"e1003723","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":98,"title":["Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate"],"prefix":"10.1371","volume":"9","author":[{"given":"Rapha\u00ebl M.","family":"Zellweger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Eddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujan","family":"Shresta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","article-title":"Dengue","volume":"370","author":"SB Halstead","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","article-title":"Immune response to dengue virus and prospects for a vaccine","volume":"29","author":"BR Murphy","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1038\/nrmicro2460","article-title":"Dengue: a continuing global threat","volume":"8","author":"MG Guzman","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"S Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref5","first-page":"301","article-title":"Immune enhancement of viral infection","volume":"31","author":"SB Halstead","year":"1982","journal-title":"Prog Allergy"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"SB Halstead","year":"2003","journal-title":"Adv Virus Res"},{"key":"ref7","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"SB Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"e1000790","DOI":"10.1371\/journal.ppat.1000790","article-title":"Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification","volume":"6","author":"SJ Balsitis","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.chom.2010.01.004","article-title":"Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease","volume":"7","author":"RM Zellweger","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.chom.2007.09.015","article-title":"Complement protein C1q inhibits antibody-dependent enhancement of flavivirus infection in an IgG subclass-specific manner","volume":"2","author":"E Mehlhop","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"TC Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","volume":"380","author":"A Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00678.x","article-title":"Understanding the contribution of cellular immunity to dengue disease pathogenesis","volume":"225","author":"A Mathew","year":"2008","journal-title":"Immunol Rev"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(12)61510-4","article-title":"Dengue vaccine development: a 75% solution?","volume":"380","author":"SB Halstead","year":"2012","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.3390\/v3122374","article-title":"The human antibody response to dengue virus infection","volume":"3","author":"WM Wahala","year":"2011","journal-title":"Viruses"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"P Pushko","year":"1997","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1128\/CVI.00258-12","article-title":"Phase I safety and immunogenicity evaluations of an alphavirus replicon HIV-1 subtype C gag vaccine in healthy HIV-1-uninfected adults","volume":"19","author":"M Wecker","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1016\/j.vaccine.2007.09.038","article-title":"Development and preclinical evaluation of an alphavirus replicon vaccine for influenza","volume":"25","author":"B Hubby","year":"2007","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.vaccine.2009.09.135","article-title":"Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers","volume":"28","author":"DI Bernstein","year":"2009","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.00512-07","article-title":"An immunogenic and protective alphavirus replicon particle-based dengue vaccine overcomes maternal antibody interference in weanling mice","volume":"81","author":"LJ White","year":"2007","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1128\/JVI.02298-12","article-title":"An alphavirus vector based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection","volume":"87","author":"LJ White","year":"2013","journal-title":"J Virol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"12561","DOI":"10.1128\/JVI.06743-11","article-title":"Gamma Interferon (IFN-gamma) Receptor Restricts Systemic Dengue Virus Replication and Prevents Paralysis in IFN-alpha\/beta Receptor-Deficient Mice","volume":"86","author":"TR Prestwood","year":"2012","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.1128\/JVI.00062-06","article-title":"Murine model for dengue virus-induced lethal disease with increased vascular permeability","volume":"80","author":"S Shresta","year":"2006","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e1002934","DOI":"10.1371\/journal.ppat.1002934","article-title":"DENV inhibits type I IFN production in infected cells by cleaving human STING","volume":"8","author":"S Aguirre","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.chom.2010.10.007","article-title":"Mouse STAT2 restricts early dengue virus replication","volume":"8","author":"J Ashour","year":"2010","journal-title":"Cell Host Microbe"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e1002780","DOI":"10.1371\/journal.ppat.1002780","article-title":"Dengue virus targets the adaptor protein MITA to subvert host innate immunity","volume":"8","author":"CY Yu","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e1003157","DOI":"10.1371\/journal.ppat.1003157","article-title":"Therapeutic Efficacy of Antibodies Lacking FcgammaR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies","volume":"9","author":"KL Williams","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"16922","DOI":"10.1073\/pnas.1010867107","article-title":"Immunodominant T-cell responses to dengue virus NS3 are associated with DHF","volume":"107","author":"T Duangchinda","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0065-3527(03)60010-2","article-title":"Immunology and immunopathogenesis of dengue disease","volume":"60","author":"AL Rothman","year":"2003","journal-title":"Adv Virus Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.4049\/jimmunol.1101970","article-title":"Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design","volume":"187","author":"D Weiskopf","year":"2011","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/rmv.360","article-title":"Alphavirus vectors and vaccination","volume":"12","author":"JO Rayner","year":"2002","journal-title":"Rev Med Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.vaccine.2012.04.030","article-title":"Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles","volume":"30","author":"DR Tonkin","year":"2012","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1073\/pnas.0600287103","article-title":"Mucosal and systemic adjuvant activity of alphavirus replicon particles","volume":"103","author":"JM Thompson","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.vaccine.2008.05.046","article-title":"Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen","volume":"26","author":"JM Thompson","year":"2008","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.4049\/jimmunol.0801974","article-title":"A protective role for dengue virus-specific CD8+ T cells","volume":"182","author":"LE Yauch","year":"2009","journal-title":"J Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/nm.2997","article-title":"Defeating dengue: a challenge for a vaccine","volume":"18","journal-title":"Nat Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/infdis\/jis749","article-title":"The Dengue Human Challenge Model: Has the Time Come to Accept This Challenge?","volume":"207","author":"AP Durbin","year":"2013","journal-title":"J Infect Dis"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nrmicro1690","article-title":"Prospects for a dengue virus vaccine","volume":"5","author":"SS Whitehead","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.virol.2008.08.008","article-title":"Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model","volume":"380","author":"JL Kyle","year":"2008","journal-title":"Virology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"8411","DOI":"10.1128\/JVI.00611-08","article-title":"A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads","volume":"82","author":"TR Prestwood","year":"2008","journal-title":"J Virol"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T08:02:14Z","timestamp":1540368134000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003723"}},"subtitle":[],"editor":[{"given":"Ron A. M.","family":"Fouchier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,31]]},"references-count":40,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003723","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,31]]}}}